625 related articles for article (PubMed ID: 3146398)
1. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
[TBL] [Abstract][Full Text] [Related]
2. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
3. Diazoxide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic beta-cells.
Schwanstecher C; Dickel C; Ebers I; Lins S; Zünkler BJ; Panten U
Br J Pharmacol; 1992 Sep; 107(1):87-94. PubMed ID: 1422580
[TBL] [Abstract][Full Text] [Related]
4. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
5. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
Lee K; Ozanne SE; Hales CN; Ashford ML
Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
[TBL] [Abstract][Full Text] [Related]
6. RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.
Bränström R; Höög A; Wahl MA; Berggren PO; Larsson O
FEBS Lett; 1997 Jul; 411(2-3):301-7. PubMed ID: 9271225
[TBL] [Abstract][Full Text] [Related]
7. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
8. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
Anello M; Gilon P; Henquin JC
Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Zünkler BJ; Lenzen S; Männer K; Panten U; Trube G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):225-30. PubMed ID: 2452991
[TBL] [Abstract][Full Text] [Related]
10. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
[TBL] [Abstract][Full Text] [Related]
11. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line.
Dunne MJ; Illot MC; Peterson OH
J Membr Biol; 1987; 99(3):215-24. PubMed ID: 2447283
[TBL] [Abstract][Full Text] [Related]
12. Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle.
Faivre JF; Findlay I
Biochim Biophys Acta; 1989 Aug; 984(1):1-5. PubMed ID: 2504288
[TBL] [Abstract][Full Text] [Related]
13. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
Harvey J; Ashford ML
Br J Pharmacol; 1998 Aug; 124(7):1557-65. PubMed ID: 9723971
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of diazoxide on ATP-K+ currents recorded from an insulin-secreting cell line.
Kozlowski RZ; Hales CN; Ashford ML
Br J Pharmacol; 1989 Aug; 97(4):1039-50. PubMed ID: 2676059
[TBL] [Abstract][Full Text] [Related]
15. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells.
Trube G; Rorsman P; Ohno-Shosaku T
Pflugers Arch; 1986 Nov; 407(5):493-9. PubMed ID: 2431383
[TBL] [Abstract][Full Text] [Related]
17. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
Garrino MG; Plant TD; Henquin JC
Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
Ball AJ; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
[TBL] [Abstract][Full Text] [Related]
19. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
20. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
